サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1426412

パクリタキセル注射の世界市場レポート 2024

Paclitaxel Injection Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
パクリタキセル注射の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

パクリタキセル注射の市場規模は、今後数年間で急速に成長すると予想されています。 2028年には13.1%の年間複合成長率（CAGR）で98億5,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、個別化医療アプローチの採用、バイオシミラーの開発、高齢化社会におけるがんの負担の増大、ドラッグデリバリーシステムの進歩、およびヘルスケア政策の変化に起因すると考えられます。予測期間の主な動向には、腫瘍学における人工知能の統合、遠隔医療および遠隔ヘルスケアサービスの拡大、ドラッグデリバリーにおける技術革新、ドラッグデリバリー技術の組み込み、バイオシミラーの台頭などが含まれます。

予想される乳がん症例の増加は、将来のパクリタキセル注射市場の成長を促進する態勢が整っています。乳がんは、乳房内の異常な細胞増殖を特徴とし、しばしば腫瘍を形成する、一般的な疾患です。化学療法薬であるパクリタキセル注射は、微小管に結合してがん細胞の増殖を阻害することで乳がんの治療に役立ちます。米国癌協会の2023年1月の推計によると、米国では浸潤性乳癌の新規症例が約297,790件発生し、2023年には推定43,700人が死亡すると予想されています。したがって、乳がんの罹患率の増加は、パクリタキセル注射剤市場の成長を促進する重要な要因です。

がんの全体的な発生率の増加により、パクリタキセル注射市場はさらに押し上げられると予想されます。タバコやアルコールの消費量の増加などの要因が、世界のがん症例の増加に寄与しています。化学療法薬であるパクリタキセルは、乳がん、肺がん、卵巣がんなどのさまざまながんの治療に一般的に使用されています。がんの発生率は増加し続けるため、パクリタキセルを重要な成分として使用する化学療法の需要は増加すると予想されます。国立がん研究所の2021年の報告書によると、がんは世界中で主な死因となっており、米国だけで推定新規感染者数1,806,590人、死亡者数606,520人となっています。 2040年までに、年間がん症例数は2,950万人に達し、がん関連死亡者数は1,640万人に達すると予測されています。したがって、がんの発生率の増加は、パクリタキセル注射市場の成長の重要な推進力です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界のパクリタキセル注射市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 天然パクリタキセル
  • 半合成パクリタキセル
  • 世界のパクリタキセル注射市場、薬剤強度別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 10mg/mL
  • 20mg/mL
  • 30mg/mL
  • 世界のパクリタキセル注射市場、適応症別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 乳がん
  • 前立腺がん
  • 精巣がん
  • 非小細胞肺がん
  • 肺がん
  • その他の適応症
  • 世界のパクリタキセル注射市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院薬局
  • オンライン薬局
  • 小売薬局
  • 世界のパクリタキセル注射市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • クリニック
  • がん研究

第7章 地域および国の分析

  • 世界のパクリタキセル注射市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
  • 世界のパクリタキセル注射市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • パクリタキセル注射市場の競合情勢
  • パクリタキセル注射市場の企業プロファイル
    • Pfizer Inc.
    • Bristol-Myers Squibb Company
    • Fresenius Kabi Oncology Ltd.
    • Abbott Laboratories
    • Viatris Inc.

第31章 その他の大手および革新的な企業

  • Teva Pharmaceutical Industries Limited
  • Sandoz International GmbH
  • Hospira Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Apotex Inc.
  • Intas Pharmaceuticals Ltd.
  • Zydus Lifesciences Limited
  • Torrent Pharmaceuticals Ltd.
  • Luye Pharma Group
  • Biological E Limited
  • Alembic Pharmaceuticals Limited
  • Khandelwal Laboratories Pvt. Ltd.
  • Gland Pharma Limited
  • Abraxis Bio Science Inc.
  • Novasep Holding SAS

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13424

Paclitaxel injection is a chemotherapy drug used in cancer treatment, typically administered through infusion into a vein in a hospital or clinic by a trained healthcare professional. Its mechanism of action involves disrupting the division and growth of cancer cells, ultimately leading to their destruction.

The primary types of paclitaxel injection are natural paclitaxel and semi-synthetic paclitaxel. Natural paclitaxel is a tetracyclic diterpenoid initially extracted from sources such as the bark of the Pacific yew tree, Taxus brevifolia. It is available in various drug strengths, including 10mg/ml, 20mg/ml, and 30mg/ml, and is utilized for the treatment of various cancers such as breast cancer, prostate cancer, testicular cancer, non-small cell lung cancer, lung cancer, among others. These injections are distributed through various channels, including hospital pharmacies, online pharmacies, and retail pharmacies, and are used by end-users such as hospitals, clinics, and cancer research institutes.

The paclitaxel injection market research report is one of a series of new reports from The Business Research Company that provides paclitaxel injection market statistics, including paclitaxel injection industry global market size, regional shares, competitors with a paclitaxel injection market share, detailed paclitaxel injection market segments, market trends and opportunities, and any further data you may need to thrive in the paclitaxel injection industry. This paclitaxel injection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The paclitaxel injection market size has grown rapidly in recent years. It will grow from $5.26 billion in 2023 to $6.02 billion in 2024 at a compound annual growth rate (CAGR) of 14.4%. The expansion observed in the historical period can be attributed to factors such as clinical research and trials, a rising incidence of cancer, increased patient awareness and education, and the globalization of the pharmaceutical industry.

The paclitaxel injection market size is expected to see rapid growth in the next few years. It will grow to $9.85 billion in 2028 at a compound annual growth rate (CAGR) of 13.1%. The anticipated growth in the forecast period can be attributed to the adoption of personalized medicine approaches, the development of biosimilars, the increasing burden of cancer in the aging population, advancements in drug delivery systems, and changes in healthcare policies. Key trends in the forecast period encompass the integration of artificial intelligence in oncology, the expansion of telemedicine and remote healthcare services, technological innovations in drug delivery, the incorporation of drug delivery technologies, and the rise of biosimilars.

The anticipated rise in breast cancer cases is poised to drive the growth of the paclitaxel injection market in the future. Breast cancer, characterized by abnormal cell growth in the breast, often forming tumors, is a prevalent condition. Paclitaxel injection, a chemotherapy drug, is instrumental in treating breast cancer by binding to microtubules, disrupting the growth of cancer cells. According to the American Cancer Society's January 2023 estimate, approximately 297,790 new cases of invasive breast cancer are expected in the US, leading to an estimated 43,700 deaths in 2023. Thus, the increasing incidence of breast cancer is a significant factor propelling the growth of the paclitaxel injection market.

The growing overall incidence of cancer is expected to further boost the paclitaxel injection market. Factors such as increased tobacco and alcohol consumption contribute to the rise in cancer cases globally. Paclitaxel, a chemotherapy medication, is commonly employed in treating various cancers, including breast, lung, and ovarian cancers. As cancer incidence continues to escalate, the demand for chemotherapy, with paclitaxel as a vital component, is expected to increase. The National Cancer Institute's 2021 report indicates that cancer is a leading cause of death worldwide, with an estimated 1,806,590 new cases and 606,520 deaths in the US alone. By 2040, the annual number of cancer cases is projected to reach 29.5 million, resulting in 16.4 million cancer-related deaths. Therefore, the rising cancer incidence is a key driver for the growth of the paclitaxel injection market.

The existence of alternatives to paclitaxel injection products may pose a limitation to market growth. The development of alternative Paclitaxel nano-delivery systems is driven by the severe side effects associated with existing formulations. Alternative delivery systems have the potential to reduce side effects, challenging the market for conventional paclitaxel injection products. For instance, the FDA granted accelerated approval to dabrafenib in combination with trametinib for the treatment of solid tumors with the BRAF V600E mutation. Thus, the availability of alternatives presents a challenge to the paclitaxel injection market.

Key companies in the paclitaxel injection market are focusing on innovation, introducing advanced products featuring materials such as protein-bound particles (PBPs) to meet consumer needs. PBPs represent a drug delivery system that utilizes albumin, a naturally occurring blood protein, to bind to drugs. Apotex Corp launched Paclitaxel protein-bound particles for injection (albumin-bound), a generic version of Abraxanes, offering an alternative for the treatment of non-small cell lung cancer and metastatic breast cancer.

In August 2022, American Regent Inc. acquired HBT Labs Inc., aiming to expand its product portfolio in the cancer medicine market. This acquisition enables American Regent to support the release of HBT's FDA-approved drug using paclitaxel protein-bound particles for injectable suspension (albumin-bound), a dried powder that can be remixed at 100 mg/vial. HBT Labs Inc. specializes in developing paclitaxel protein-bound particles for injectable suspension.

Major companies operating in the paclitaxel injection market report are Pfizer Inc., Bristol-Myers Squibb Company, Fresenius Kabi Oncology Ltd., Abbott Laboratories, Viatris Inc., Teva Pharmaceutical Industries Limited, Sandoz International GmbH, Hospira Inc., Dr. Reddy's Laboratories Ltd., Apotex Inc., Intas Pharmaceuticals Ltd., Zydus Lifesciences Limited, Torrent Pharmaceuticals Ltd., Luye Pharma Group, Biological E Limited, Alembic Pharmaceuticals Limited, Khandelwal Laboratories Pvt. Ltd., Gland Pharma Limited, Abraxis Bio Science Inc., Novasep Holding SAS, Sagent Pharmaceuticals Inc., Hainan Haiyao Co Ltd., Accord Healthcare Ltd., Natco Pharma Limited, Strides Pharma Science Limited, Panacea Biotec Ltd., American Regent Inc., MSN Laboratories Pvt Ltd., Hetero Drugs Ltd.

North America was the largest region in the paclitaxel injection market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the paclitaxel injection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the paclitaxel injection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The paclitaxel injection market consists of sales of conventional paclitaxel injection, albumin-bound paclitaxel injection, nanoparticle albumin-bound paclitaxel, and liposomal paclitaxel. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Paclitaxel Injection Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on paclitaxel injection market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for paclitaxel injection? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The paclitaxel injection market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Natural Paclitaxel; Semi-synthetic Paclitaxel
  • 2) By Drug Strength: 10mg/mL; 20mg/mL; 30mg/mL
  • 3) By Indication: Breast Cancer; Prostate Cancer; Testicular Cancer; Non-Small Cell Lung Cancer; Lung Cancer; Other Indications
  • 4) By Distribution Channel: Hospital Pharmacies; Online Pharmacies; Retail Pharmacies
  • 5) By End User: Hospitals; Clinics; Cancer Research Institute
  • Companies Mentioned: Pfizer Inc.; Bristol-Myers Squibb Company; Fresenius Kabi Oncology Ltd.; Abbott Laboratories; Viatris Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Paclitaxel Injection Market Characteristics

3. Paclitaxel Injection Market Trends And Strategies

4. Paclitaxel Injection Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Paclitaxel Injection Market Size and Growth

  • 5.1. Global Paclitaxel Injection Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Paclitaxel Injection Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Paclitaxel Injection Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Paclitaxel Injection Market Segmentation

  • 6.1. Global Paclitaxel Injection Market, Segmentation By Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Natural Paclitaxel
  • Semi-synthetic Paclitaxel
  • 6.2. Global Paclitaxel Injection Market, Segmentation By Drug Strength , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10mg/mL
  • 20mg/mL
  • 30mg/mL
  • 6.3. Global Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Breast Cancer
  • Prostate Cancer
  • Testicular Cancer
  • Non-Small Cell Lung Cancer
  • Lung Cancer
  • Other Indications
  • 6.4. Global Paclitaxel Injection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • 6.5. Global Paclitaxel Injection Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Clinics
  • Cancer Research Institute

7. Paclitaxel Injection Market Regional And Country Analysis

  • 7.1. Global Paclitaxel Injection Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Paclitaxel Injection Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Paclitaxel Injection Market

  • 8.1. Asia-Pacific Paclitaxel Injection Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Paclitaxel Injection Market, Segmentation By Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Paclitaxel Injection Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Paclitaxel Injection Market

  • 9.1. China Paclitaxel Injection Market Overview
  • 9.2. China Paclitaxel Injection Market, Segmentation By Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Paclitaxel Injection Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Paclitaxel Injection Market

  • 10.1. India Paclitaxel Injection Market, Segmentation By Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Paclitaxel Injection Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Paclitaxel Injection Market

  • 11.1. Japan Paclitaxel Injection Market Overview
  • 11.2. Japan Paclitaxel Injection Market, Segmentation By Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Paclitaxel Injection Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Paclitaxel Injection Market

  • 12.1. Australia Paclitaxel Injection Market, Segmentation By Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Paclitaxel Injection Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Paclitaxel Injection Market

  • 13.1. Indonesia Paclitaxel Injection Market, Segmentation By Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Paclitaxel Injection Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Paclitaxel Injection Market

  • 14.1. South Korea Paclitaxel Injection Market Overview
  • 14.2. South Korea Paclitaxel Injection Market, Segmentation By Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Paclitaxel Injection Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Paclitaxel Injection Market

  • 15.1. Western Europe Paclitaxel Injection Market Overview
  • 15.2. Western Europe Paclitaxel Injection Market, Segmentation By Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Paclitaxel Injection Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Paclitaxel Injection Market

  • 16.1. UK Paclitaxel Injection Market, Segmentation By Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Paclitaxel Injection Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Paclitaxel Injection Market

  • 17.1. Germany Paclitaxel Injection Market, Segmentation By Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Paclitaxel Injection Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Paclitaxel Injection Market

  • 18.5. France Paclitaxel Injection Market, Segmentation By Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Paclitaxel Injection Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Paclitaxel Injection Market

  • 19.9. Italy Paclitaxel Injection Market, Segmentation By Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Paclitaxel Injection Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Paclitaxel Injection Market

  • 20.13. Spain Paclitaxel Injection Market, Segmentation By Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Paclitaxel Injection Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Paclitaxel Injection Market

  • 21.1. Eastern Europe Paclitaxel Injection Market Overview
  • 21.2. Eastern Europe Paclitaxel Injection Market, Segmentation By Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Paclitaxel Injection Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Paclitaxel Injection Market

  • 22.1. Russia Paclitaxel Injection Market, Segmentation By Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Paclitaxel Injection Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Paclitaxel Injection Market

  • 23.1. North America Paclitaxel Injection Market Overview
  • 23.2. North America Paclitaxel Injection Market, Segmentation By Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Paclitaxel Injection Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Paclitaxel Injection Market

  • 24.1. USA Paclitaxel Injection Market Overview
  • 24.2. USA Paclitaxel Injection Market, Segmentation By Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Paclitaxel Injection Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Paclitaxel Injection Market

  • 25.1. Canada Paclitaxel Injection Market Overview
  • 25.2. Canada Paclitaxel Injection Market, Segmentation By Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Paclitaxel Injection Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Paclitaxel Injection Market

  • 26.1. South America Paclitaxel Injection Market Overview
  • 26.2. South America Paclitaxel Injection Market, Segmentation By Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Paclitaxel Injection Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Paclitaxel Injection Market

  • 27.1. Brazil Paclitaxel Injection Market, Segmentation By Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Paclitaxel Injection Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Paclitaxel Injection Market

  • 28.1. Middle East Paclitaxel Injection Market Overview
  • 28.2. Middle East Paclitaxel Injection Market, Segmentation By Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Paclitaxel Injection Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Paclitaxel Injection Market

  • 29.1. Africa Paclitaxel Injection Market Overview
  • 29.2. Africa Paclitaxel Injection Market, Segmentation By Type , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Paclitaxel Injection Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Paclitaxel Injection Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Paclitaxel Injection Market Competitive Landscape And Company Profiles

  • 30.1. Paclitaxel Injection Market Competitive Landscape
  • 30.2. Paclitaxel Injection Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Bristol-Myers Squibb Company
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Fresenius Kabi Oncology Ltd.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Abbott Laboratories
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Viatris Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Paclitaxel Injection Market Other Major And Innovative Companies

  • 31.1. Teva Pharmaceutical Industries Limited
  • 31.2. Sandoz International GmbH
  • 31.3. Hospira Inc.
  • 31.4. Dr. Reddy's Laboratories Ltd.
  • 31.5. Apotex Inc.
  • 31.6. Intas Pharmaceuticals Ltd.
  • 31.7. Zydus Lifesciences Limited
  • 31.8. Torrent Pharmaceuticals Ltd.
  • 31.9. Luye Pharma Group
  • 31.10. Biological E Limited
  • 31.11. Alembic Pharmaceuticals Limited
  • 31.12. Khandelwal Laboratories Pvt. Ltd.
  • 31.13. Gland Pharma Limited
  • 31.14. Abraxis Bio Science Inc.
  • 31.15. Novasep Holding SAS

32. Global Paclitaxel Injection Market Competitive Benchmarking

33. Global Paclitaxel Injection Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Paclitaxel Injection Market

35. Paclitaxel Injection Market Future Outlook and Potential Analysis

  • 35.1 Paclitaxel Injection Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Paclitaxel Injection Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Paclitaxel Injection Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer